We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Research Letter |

Association of CYP2C19 *17/*17 Genotype With the Risk of Voriconazole-Associated Squamous Cell Carcinoma

Kiyanna Williams, BS1; Sarah T. Arron, MD, PhD2
[+] Author Affiliations
1Medical student at University of California, San Francisco, School of Medicine
2Department of Dermatology, University of California, San Francisco
JAMA Dermatol. 2016;152(6):719-720. doi:10.1001/jamadermatol.2016.0351.
Text Size: A A A
Published online


This cohort study investigates whether lung transplant recipients with the ultrarapid-metabolizing *17 allele of CYP2C19 have an increased risk for voriconazole-associated cutaneous squamous cell carcinoma.

An estimated 25 767 solid-organ transplantations were performed in 2015.1 Voriconazole, an antifungal used in organ transplant recipients, is associated with a 73% increased risk for cutaneous squamous cell carcinoma (SCC) development in lung transplant recipients (LTRs).2 The mechanism of voriconazole-associated cutaneous malignant neoplasm development is unknown, but the primary metabolite of voriconazole, voriconazole-N-oxide (VNO), is a chromophore for UVB and may play a key role in DNA damage resulting in SCC. Voriconazole is primarily metabolized into VNO by cytochrome P450 enzymes, predominantly CYP2C19 (2-4). Polymorphisms in CYP2C19 affect circulating levels of voriconazole and VNO, with poor metabolizers having 3 to 4 times higher voriconazole plasma concentrations and greater voriconazole to VNO ratios.35 The ultrarapid-metabolizing *17 allele of CYP2C19 (OMIM 124020), which is common in Europeans and Africans and rare in Asians, results in higher circulating concentrations of VNO. We hypothesized that LTRs with the *17 allele would have an increased risk for voriconazole-associated SCC.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections